Literature DB >> 27115060

Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes.

Jessica R Furst1, Leonardo C Bandeira1, Wen-Wei Fan1, Sanchita Agarwal1, Kyle K Nishiyama1, Donald J McMahon1, Elzbieta Dworakowski1, Hongfeng Jiang1, Shonni J Silverberg1, Mishaela R Rubin1.   

Abstract

CONTEXT: Skeletal deterioration, leading to an increased risk of fracture, is a known complication of type 2 diabetes mellitus (T2D). Yet plausible mechanisms to account for skeletal fragility in T2D have not been clearly established.
OBJECTIVE: The objective of the study was to determine whether bone material properties, as measured by reference point indentation, and advanced glycation endproducts (AGEs), as determined by skin autofluorescence (SAF), are related in patients with T2D.
DESIGN: This was a cross-sectional study.
SETTING: The study was conducted at a tertiary medical center. PATIENTS: Sixteen postmenopausal women with T2D and 19 matched controls participated in the study. MAIN OUTCOME MEASURES: Bone material strength index (BMSi) by in vivo reference point indentation, AGE accumulation by SAF, and circulating bone turnover markers were measured.
RESULTS: BMSi was reduced by 9.2% in T2D (P = .02) and was inversely associated with the duration of T2D (r = -0.68, P = .004). Increased SAF was associated with reduced BMSi (r = -0.65, P = .006) and lower bone formation marker procollagen type 1 amino-terminal propeptide (r = -0.63, P = .01) in T2D, whereas no associations were seen in controls. SAF accounted for 26% of the age-adjusted variance in BMSi in T2D (P = .03).
CONCLUSIONS: Bone material properties are impaired in postmenopausal women with T2D as determined by reference point indentation. The results suggest a role for the accumulation of AGEs to account for inferior BMSi in T2D.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27115060      PMCID: PMC4891790          DOI: 10.1210/jc.2016-1437

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  51 in total

1.  Effects of non-enzymatic glycation on cancellous bone fragility.

Authors:  S Y Tang; U Zeenath; D Vashishth
Journal:  Bone       Date:  2006-12-21       Impact factor: 4.398

2.  In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Authors:  Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

Review 3.  Type 2 diabetes and bone.

Authors:  William D Leslie; Mishaela R Rubin; Ann V Schwartz; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-09-28       Impact factor: 6.741

4.  Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material Strength.

Authors:  Connor Randall; Daniel Bridges; Roberto Guerri; Xavier Nogues; Lluis Puig; Elisa Torres; Leonardo Mellibovsky; Kevin Hoffseth; Tyler Stalbaum; Ananya Srikanth; James C Weaver; Sasha Rosen; Heather Barnard; Davis Brimer; Alex Proctor; James Candy; Christopher Saldana; Srinivasan Chandrasekar; Timothy Lescun; Carrie M Nielson; Eric Orwoll; Doug Herthel; Hal Kopeikin; Henry T Y Yang; Joshua N Farr; Louise McCready; Sundeep Khosla; Adolfo Diez-Perez; Paul K Hansma
Journal:  J Med Device       Date:  2013-09-24       Impact factor: 0.582

5.  Age-related patterns of trabecular and cortical bone loss differ between sexes and skeletal sites: a population-based HR-pQCT study.

Authors:  Heather M Macdonald; Kyle K Nishiyama; Jian Kang; David A Hanley; Steven K Boyd
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

6.  Bone structure and turnover in type 2 diabetes mellitus.

Authors:  A Shu; M T Yin; E Stein; S Cremers; E Dworakowski; R Ives; M R Rubin
Journal:  Osteoporos Int       Date:  2011-03-19       Impact factor: 4.507

7.  Diabetes and fracture risk in older U.S. adults.

Authors:  Anne C Looker; Mark S Eberhardt; Sharon H Saydah
Journal:  Bone       Date:  2015-01-07       Impact factor: 4.398

Review 8.  Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties.

Authors:  Lamya Karim; Mary L Bouxsein
Journal:  Bone       Date:  2015-07-23       Impact factor: 4.398

9.  Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease.

Authors:  Vikram V Shanbhogue; Stinus Hansen; Morten Frost; Niklas Rye Jørgensen; Anne Pernille Hermann; Jan Erik Henriksen; Kim Brixen
Journal:  Eur J Endocrinol       Date:  2015-11-04       Impact factor: 6.664

10.  A High Amount of Local Adipose Tissue Is Associated With High Cortical Porosity and Low Bone Material Strength in Older Women.

Authors:  Daniel Sundh; Robert Rudäng; Michail Zoulakis; Anna G Nilsson; Anna Darelid; Mattias Lorentzon
Journal:  J Bone Miner Res       Date:  2015-12-22       Impact factor: 6.741

View more
  50 in total

1.  Pentosidine Is Associated With Cortical Bone Geometry and Insulin Resistance in Otherwise Healthy Children.

Authors:  Joseph M Kindler; Emma M Laing; Weixi Liu; Joel A Dain; Richard D Lewis
Journal:  J Bone Miner Res       Date:  2019-06-20       Impact factor: 6.741

2.  Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes.

Authors:  Lamya Karim; Julia Moulton; Miranda Van Vliet; Kelsey Velie; Ann Robbins; Fatemeh Malekipour; Ayesha Abdeen; Douglas Ayres; Mary L Bouxsein
Journal:  Bone       Date:  2018-05-30       Impact factor: 4.398

3.  Local bone quality measurements correlates with maximum screw torque at the femoral diaphysis.

Authors:  Christopher M McAndrew; Avinesh Agarwalla; Adam C Abraham; Eric Feuchtbaum; William M Ricci; Simon Y Tang
Journal:  Clin Biomech (Bristol, Avon)       Date:  2018-02-03       Impact factor: 2.063

Review 4.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

Review 5.  Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.

Authors:  Erin M B McNerny; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

6.  Low bone toughness in the TallyHO model of juvenile type 2 diabetes does not worsen with age.

Authors:  Amy Creecy; Sasidhar Uppuganti; Mustafa Unal; R Clay Bunn; Paul Voziyan; Jeffry S Nyman
Journal:  Bone       Date:  2018-02-10       Impact factor: 4.398

7.  Advanced Glycation End Products: Building on the Concept of the "Common Soil" in Metabolic Disease.

Authors:  Henry H Ruiz; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

Review 8.  The Impact of Fat and Obesity on Bone Microarchitecture and Strength in Children.

Authors:  Joshua N Farr; Paul Dimitri
Journal:  Calcif Tissue Int       Date:  2016-12-24       Impact factor: 4.333

Review 9.  Assessment of bone quality in patients with diabetes mellitus.

Authors:  N Jiang; W Xia
Journal:  Osteoporos Int       Date:  2018-05-07       Impact factor: 4.507

Review 10.  The Effect of Type 2 Diabetes on Bone Biomechanics.

Authors:  Lamya Karim; Taraneh Rezaee; Rachana Vaidya
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.